- Home
- MNPR vs FMAO Comparison
MNPR vs FMAO Comparison
Compare MNPR & FMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- FMAO
- Stock Information
- Founded
- MNPR 2014
- FMAO 1897
- Country
- MNPR United States
- FMAO United States
- Employees
- MNPR N/A
- FMAO N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- FMAO Savings Institutions
- Sector
- MNPR Health Care
- FMAO Finance
- Exchange
- MNPR Nasdaq
- FMAO Nasdaq
- Market Cap
- MNPR 390.5M
- FMAO 358.1M
- IPO Year
- MNPR 2019
- FMAO N/A
- Fundamental
- Price
- MNPR $99.37
- FMAO $24.97
- Analyst Decision
- MNPR Strong Buy
- FMAO
- Analyst Count
- MNPR 12
- FMAO 0
- Target Price
- MNPR $89.82
- FMAO N/A
- AVG Volume (30 Days)
- MNPR 78.9K
- FMAO 24.0K
- Earning Date
- MNPR 11-07-2025
- FMAO 10-29-2025
- Dividend Yield
- MNPR N/A
- FMAO 3.58%
- EPS Growth
- MNPR N/A
- FMAO 38.39
- EPS
- MNPR N/A
- FMAO 2.16
- Revenue
- MNPR N/A
- FMAO $108,632,000.00
- Revenue This Year
- MNPR N/A
- FMAO $3.38
- Revenue Next Year
- MNPR N/A
- FMAO $6.39
- P/E Ratio
- MNPR N/A
- FMAO $11.44
- Revenue Growth
- MNPR N/A
- FMAO 13.86
- 52 Week Low
- MNPR $4.50
- FMAO $20.88
- 52 Week High
- MNPR $105.00
- FMAO $34.15
- Technical
- Relative Strength Index (RSI)
- MNPR 88.79
- FMAO 44.91
- Support Level
- MNPR $72.41
- FMAO $24.21
- Resistance Level
- MNPR $105.00
- FMAO $26.45
- Average True Range (ATR)
- MNPR 7.21
- FMAO 0.83
- MACD
- MNPR 2.86
- FMAO -0.13
- Stochastic Oscillator
- MNPR 89.52
- FMAO 28.38
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About FMAO Farmers & Merchants Bancorp Inc.
Farmers & Merchants Bancorp Inc is a holding company based in Ohio. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.